Three-Year Outcome After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease
- 9 March 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (9) , 1114-1120
- https://doi.org/10.1161/01.cir.0000118504.61212.4b
Abstract
Background— The primary results of Arterial Revascularization Therapy Study reported a greater need for repeated revascularization after percutaneous coronary intervention with stenting (PCI). However, PCI was less expensive than coronary artery bypass grafting (CABG) and offered the same degree of protection against death, stroke, and myocardial infarction. Methods and Results— Patients with multivessel disease (n=1205) were randomly assigned to either CABG or PCI and followed up for up to 3 years. Survival rates without stroke or myocardial infarction were similar in each group at 1 year and 3 years (90.5% versus 91.4% for PCI versus CABG at 1 year and 87.2% versus 88.4% for PCI versus CABG at 3 years). However, the respective repeat revascularization rates were 21.2% and 26.7% at 1 and 3 years in patients allocated to PCI, compared with 3.8% and 6.6% in patients allocated to CABG (P<0.0001). Diabetes (P<0.0009) and maximal pressure for stent deployment (P<0.002) are the strongest independent predictors...Keywords
This publication has 21 references indexed in Scilit:
- Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel DiseaseNew England Journal of Medicine, 2001
- Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic statusJournal of the American College of Cardiology, 2000
- Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery?: The bypass angioplasty revascularization investigation (BARI)Journal of the American College of Cardiology, 1999
- The ARTS (Arterial Revascularization Therapies Study): Background, goals and methodsInternational Journal of Cardiovascular Interventions, 1999
- Analysis of the Relative Costs and Effectiveness of Primary Angioplasty Versus Tissue-Type Plasminogen Activator: The Primary Angioplasty in Myocardial Infarction (PAMI) TrialJournal of the American College of Cardiology, 1997
- Medical Care Costs and Quality of Life after Randomization to Coronary Angioplasty or Coronary Bypass SurgeryNew England Journal of Medicine, 1997
- A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multivessel coronary artery diseaseThe American Journal of Cardiology, 1995
- Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): In-hospital results and 1-year follow-upJournal of the American College of Cardiology, 1993
- Progression of atherosclerosis in coronary arteries and bypass grafts: Ten years laterThe American Journal of Cardiology, 1984
- Fieller's theorem and a generalizationBiometrika, 1967